85275-46-3

Basic information

• Product Name: 1-BOC-3-(TOLUENE-4-SULFONYLOXY)-PIPERIDINE
• Synonyms: 1-Boc-3-(tosyloxy)piperidine;1-BOC-3-(TOLUENE-4-SULFONYLOXY)-PIPERIDINE;t-Butyl 3-(p-tolylsulfonyloxy)piperidine-1-carboxylate;1-Boc-3-(p-tolylsulfonyloxy)piperidine;1-Piperidinecarboxylic acid, 3-[[(4-Methylphenyl)sulfonyl]oxy]-, 1,1-diMethylethyl ester;tert-Butyl 3-(tosyloxy)piperidine-1-carboxylate
• CAS NO: 85275-46-3
• Molecular Formula: C17H25NO5S
• Molecular Weight: 355.45
• Mol File: 85275-46-3.mol
• Article Data: 30

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 1-BOC-3-(TOLUENE-4-SULFONYLOXY)-PIPERIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-BOC-3-(TOLUENE-4-SULFONYLOXY)-PIPERIDINE(85275-46-3)
• EPA Substance Registry System: 1-BOC-3-(TOLUENE-4-SULFONYLOXY)-PIPERIDINE(85275-46-3)

Safety Data

• Hazardous Substances Data: 85275-46-3(Hazardous Substances Data)

Usage

General Description

1-BOC-3-(TOLUENE-4-SULFONYLOXY)-PIPERIDINE is a chemical compound that consists of a piperidine ring with a BOC (tert-butoxycarbonyl) protecting group attached to the nitrogen atom, and a toluene-4-sulfonate ester group attached to one of the carbon atoms. It is commonly used as a building block in organic synthesis, particularly in the production of pharmaceuticals. The BOC group serves to protect the piperidine nitrogen from unwanted reactions, while the toluene-4-sulfonate ester can be easily substituted with other functional groups, allowing for further derivatization of the molecule. The compound is also known for its mild and selective deprotection conditions, making it a valuable tool in organic chemistry.

Upstream product

• 91599-81-4 (R)-N-benzyl-3-hydroxypiperidine 
• 91599-79-0 (S)-1-N-benzyl-3-hydroxypiperidine 
• 940890-90-4 (S)-3-methanesulfonyloxy-piperidine-1-carboxylic acid tert-butyl ester 
• 98-59-9 p-toluenesulfonyl chloride 
• 143900-43-0 tert-butyl (3R)-3-hydroxypiperidine-1-carboxylate 
• 14813-01-5 1-benzyl-3-hydroxypiperidine 
• 404577-34-0 (R)-3-methanesulfonyloxy-piperidine-1-carboxylic acid tert-butyl ester 
• 24424-99-5 di-tert-butyl dicarbonate 
• 143900-44-1 tert-butyl (3S)-3-hydroxypiperidine-1-carboxylate 
• 85275-45-2 N-tert-butoxycarbonyl-3-piperidinol 

Downstream Products

• 1558038-42-8 (R)-5-amino-3-(4-phenoxyphenyl)-1-piperidin-3-yl-1H-pyrazole-4-carboxylic acid amide 
• 1612774-51-2 (R)-tert-butyl 3-(5-amino-4-carbamoyl-3-(4-phenoxyphenyl)-1H-pyrazol-1-yl)piperidine-1-carboxylate 
• 1612774-47-6 tert-butyl 3-(5-amino-4-cyano-3-(4-phenoxyphenyl)-1H-pyrazol-1-yl)-piperidine-1-carboxylate 
• 1612773-99-5 1-(1-acryloylpiperidin-3-yl)-5-(methylamino)-3-(4-phenoxyphenyl)-1H-pyrazole-4-carboxamide 
• 1612777-08-8 tert-butyl 3-(5-(tert-butoxycarbonyl(methyl)amino)-4-cyano-3-(4-phenoxyphenyl)-1H-pyrazol-1-yl)piperidine-1-carboxylate 
• 1612774-48-7 tert-butyl 3-(5-(tert-butoxycarbonylamino)-4-cyano-3-(4-phenoxyphenyl)-1H-pyrazol-1-yl)piperidine-1-carboxylate 
• 1642571-07-0 (R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride 
• 1612774-21-6 5-amino-3-(4-phenoxyphenyl)-1-(1-(vinylsulfonyl)piperidin-3-yl)-1H-pyrazole-4-carboxamide 
• 1612774-23-8 (E)-5-amino-1-(1-(4-(dimethylamino)but-2-enoyl)piperidin-3-yl)-3-(4-phenoxyphenyl)-1H-pyrazole-4-carboxamide 
• 1612774-17-0 1-(1-acryloylpiperidin-3-yl)-5-amino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carboxamide 
• 1609467-45-9 5-amino-3-(4-phenoxyphenyl)-1-piperidin-3-yl-1H-pyrazole-4-carboxylic acid amide 
• 1612774-53-4 (R)-tert-butyl 3-(3-amino-4-cyano-5-(4-phenoxyphenyl)-1H-pyrazol-1-yl)piperidine-1-carboxylate 
• 1612774-50-1 (R)-tert-butyl 3-(5-amino-4-cyano-3-(4-phenoxyphenyl)-1H-pyrazol-1-yl)piperidine-1-carboxylate 
• 1612774-15-8 (R)-1-(1-acryloylpiperidin-3-yl)-3-amino-5-(4-phenoxyphenyl)-1H-pyrazole-4-carboxamide 

Relevant articles and documents

PROTEIN DEGRADERS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same for the targeted degradation of proteins, and the treatment of target protein-mediated disorders.

Discovery and Evaluation of Pyrazolo[3,4-d]pyridazinone as a Potent and Orally Active Irreversible BTK Inhibitor

The identification and lead optimization of a series of pyrazolo[3,4-d]pyridazinone derivatives are described as a novel class of potent irreversible BTK inhibitors, resulting in the discovery of compound 8. Compound 8 exhibited high potency against BTK kinase and acceptable PK profile. Furthermore, compound 8 demonstrated significant in vivo efficacy in a mouse-collagen-induced arthritis (CIA) model.

Therapeutic Combinations of a Proteasome Inhibitor and a BTK Inhibitor

Therapeutic combinations of a proteasome inhibitor and a Bruton's tyrosine kinase (BTK) inhibitor are described. In some embodiments, the invention provides pharmaceutical compositions comprising combinations of a proteasome inhibitor and a BTK inhibitor and methods of using the pharmaceutical compositions for treating a disease, in particular a cancer.